BIOMAT Database Logo BIOMAT Database Logo

Synthesis and in Vitro Evaluation of Novel 5-Nitroindole Derivatives as c-Myc G-Quadruplex Binders with Anticancer Activity. 2021

Vijaykumar D Nimbarte, and Julia Wirmer-Bartoschek, and Santosh L Gande, and Islam Alshamleh, and Marcel Seibert, and Hamid Reza Nasiri, and Frank Schnütgen, and Hubert Serve, and Harald Schwalbe
Institute for Organic Chemistry and Chemical Biology, Center for Biomolecular Magnetic Resonance (BMRZ), Goethe University Frankfurt, Max-von-Laue-Straße 7, 60438, Frankfurt am Main, Germany.

Lead-optimization strategies for compounds targeting c-Myc G-quadruplex (G4) DNA are being pursued to develop anticancer drugs. Here, we investigate the structure-activity- relationship (SAR) of a newly synthesized series of molecules based on the pyrrolidine-substituted 5-nitro indole scaffold to target G4 DNA. Our synthesized series allows modulation of flexible elements with a structurally preserved scaffold. Biological and biophysical analyses illustrate that substituted 5-nitroindole scaffolds bind to the c-Myc promoter G-quadruplex. These compounds downregulate c-Myc expression and induce cell-cycle arrest in the sub-G1/G1 phase in cancer cells. They further increase the concentration of intracellular reactive oxygen species. NMR spectra show that three of the newly synthesized compounds interact with the terminal G-quartets (5'- and 3'-ends) in a 2 : 1 stoichiometry.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D016259 Genes, myc Family of retrovirus-associated DNA sequences (myc) originally isolated from an avian myelocytomatosis virus. The proto-oncogene myc (c-myc) codes for a nuclear protein which is involved in nucleic acid metabolism and in mediating the cellular response to growth factors. Truncation of the first exon, which appears to regulate c-myc expression, is crucial for tumorigenicity. The human c-myc gene is located at 8q24 on the long arm of chromosome 8. L-myc Genes,N-myc Genes,c-myc Genes,myc Genes,v-myc Genes,L-myc Proto-Oncogenes,N-myc Proto-Oncogenes,c-myc Proto-Oncogenes,myc Oncogene,v-myc Oncogenes,Gene, L-myc,Gene, N-myc,Gene, c-myc,Gene, myc,Gene, v-myc,Genes, L-myc,Genes, N-myc,Genes, c-myc,Genes, v-myc,L myc Genes,L myc Proto Oncogenes,L-myc Gene,L-myc Proto-Oncogene,N myc Genes,N myc Proto Oncogenes,N-myc Gene,N-myc Proto-Oncogene,Oncogene, myc,Oncogene, v-myc,Oncogenes, myc,Oncogenes, v-myc,Proto-Oncogene, L-myc,Proto-Oncogene, N-myc,Proto-Oncogene, c-myc,Proto-Oncogenes, L-myc,Proto-Oncogenes, N-myc,Proto-Oncogenes, c-myc,c myc Genes,c myc Proto Oncogenes,c-myc Gene,c-myc Proto-Oncogene,myc Gene,myc Oncogenes,v myc Genes,v myc Oncogenes,v-myc Gene,v-myc Oncogene

Related Publications

Vijaykumar D Nimbarte, and Julia Wirmer-Bartoschek, and Santosh L Gande, and Islam Alshamleh, and Marcel Seibert, and Hamid Reza Nasiri, and Frank Schnütgen, and Hubert Serve, and Harald Schwalbe
Carbazole ligands as c-myc G-quadruplex binders.
July 2018, International journal of biological macromolecules,
Vijaykumar D Nimbarte, and Julia Wirmer-Bartoschek, and Santosh L Gande, and Islam Alshamleh, and Marcel Seibert, and Hamid Reza Nasiri, and Frank Schnütgen, and Hubert Serve, and Harald Schwalbe
Bio-Inspired Dual-Selective BCL-2/c-MYC G-Quadruplex Binders: Design, Synthesis, and Anticancer Activity of Drug-like Imidazo[2,1-i]purine Derivatives.
March 2020, Journal of medicinal chemistry,
Vijaykumar D Nimbarte, and Julia Wirmer-Bartoschek, and Santosh L Gande, and Islam Alshamleh, and Marcel Seibert, and Hamid Reza Nasiri, and Frank Schnütgen, and Hubert Serve, and Harald Schwalbe
Synthesis and evaluation of 2,9-disubstituted-1,10-phenanthroline derivatives as G-quadruplex binders.
November 2022, Bioorganic & medicinal chemistry,
Vijaykumar D Nimbarte, and Julia Wirmer-Bartoschek, and Santosh L Gande, and Islam Alshamleh, and Marcel Seibert, and Hamid Reza Nasiri, and Frank Schnütgen, and Hubert Serve, and Harald Schwalbe
Novel Naphthalimide Derivatives as Selective G-Quadruplex DNA Binders.
November 2018, Applied biochemistry and biotechnology,
Vijaykumar D Nimbarte, and Julia Wirmer-Bartoschek, and Santosh L Gande, and Islam Alshamleh, and Marcel Seibert, and Hamid Reza Nasiri, and Frank Schnütgen, and Hubert Serve, and Harald Schwalbe
Design, synthesis and biological evaluation of 4-anilinoquinazoline derivatives as new c-myc G-quadruplex ligands.
October 2016, European journal of medicinal chemistry,
Vijaykumar D Nimbarte, and Julia Wirmer-Bartoschek, and Santosh L Gande, and Islam Alshamleh, and Marcel Seibert, and Hamid Reza Nasiri, and Frank Schnütgen, and Hubert Serve, and Harald Schwalbe
Synthesis, docking studies and antitumor activity of phenanthroimidazole derivatives as promising c-myc G-quadruplex DNA stabilizers.
September 2020, Bioorganic chemistry,
Vijaykumar D Nimbarte, and Julia Wirmer-Bartoschek, and Santosh L Gande, and Islam Alshamleh, and Marcel Seibert, and Hamid Reza Nasiri, and Frank Schnütgen, and Hubert Serve, and Harald Schwalbe
Alkyne-substituted diminazene as G-quadruplex binders with anticancer activities.
August 2016, European journal of medicinal chemistry,
Vijaykumar D Nimbarte, and Julia Wirmer-Bartoschek, and Santosh L Gande, and Islam Alshamleh, and Marcel Seibert, and Hamid Reza Nasiri, and Frank Schnütgen, and Hubert Serve, and Harald Schwalbe
Structure-based virtual screening of novel natural alkaloid derivatives as potential binders of h-telo and c-myc DNA G-quadruplex conformations.
December 2014, Molecules (Basel, Switzerland),
Vijaykumar D Nimbarte, and Julia Wirmer-Bartoschek, and Santosh L Gande, and Islam Alshamleh, and Marcel Seibert, and Hamid Reza Nasiri, and Frank Schnütgen, and Hubert Serve, and Harald Schwalbe
Microwave-assisted synthesis of phenanthroimidazole derivatives as stabilizer of c-myc G-quadruplex DNA.
November 2014, Bioorganic & medicinal chemistry,
Vijaykumar D Nimbarte, and Julia Wirmer-Bartoschek, and Santosh L Gande, and Islam Alshamleh, and Marcel Seibert, and Hamid Reza Nasiri, and Frank Schnütgen, and Hubert Serve, and Harald Schwalbe
G-quadruplex-R-loop interactions and the mechanism of anticancer G-quadruplex binders.
December 2020, Nucleic acids research,
Copied contents to your clipboard!